RxDoctor Payments Data

Dianne Copenhaver

Adult Health · Ocala, FLNPI 1427010552

Payments from drug & device makers

$249in general payments, 2019–2025

Across 9 payments — averaging $27.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$129
  • Johnson & Johnson$34
  • Otsuka America Pharmaceutical, Inc.$17
  • W. L. Gore & Associates, Inc.$16
  • Medtronic$15
  • Lundbeck LLC$14
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$23695%
  • Education$145%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$249 in reported general payments places this provider in the 35th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$34,573
Medicare patients
48
Services billed
299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban25$22,511
MounjaroTirzepatide14$16,722
Ezetimibe73$1,745
ClopidogrelClopidogrel Bisulfate105$1,527
Pantoprazole Sodium37$813
Omeprazole33$746
Gabapentin37$736
Atorvastatin Calcium67$725
Potassium Chloride18$655
Amlodipine Besylate92$592
Metoprolol Succinate20$580
Tizanidine Hcl14$562
Tamsulosin Hcl28$530
Losartan Potassium47$477
Metformin Hcl45$465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$34$22,51125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 2,237 adult health providers in Florida.

Other adult health in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →